Ajanta Pharma Ltd
AJANTPHARMAjanta Pharma Ltd
AJANTPHARM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 41.29 | 10.13 | 1.79% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast from 10 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,770.52 | 2,007.12 | 2,149.92 | 2,076.45 | 2,680.06 | 2,915.67 | 3,456.67 | 3,841.28 | 4,293.31 | 4,585.83 | ||||||||||
Raw Materials | 463.10 | 425.21 | 455.63 | 440.09 | 672.46 | 795.95 | 915.44 | 1,024.64 | 1,105.78 | 3,256.88 | ||||||||||
| Power & Fuel Cost | 15.49 | 18.70 | 27.42 | 32.65 | 38.88 | 43.70 | 54.38 | 65.71 | 66.57 | |||||||||||
| Employee Cost | 256.64 | 295.42 | 376.47 | 430.71 | 485.59 | 548.25 | 645.78 | 785.14 | 900.34 | |||||||||||
| Selling & Administrative Expenses | 327.55 | 362.94 | 424.71 | 445.52 | 534.89 | 484.01 | 652.72 | 784.97 | 749.71 | |||||||||||
| Operating & Other expenses | 99.53 | 194.11 | 183.14 | 139.97 | 176.64 | 19.22 | 143.37 | 298.93 | 214.37 | |||||||||||
EBITDA | 608.21 | 710.74 | 682.55 | 587.51 | 771.60 | 1,024.54 | 1,044.98 | 881.89 | 1,256.54 | 1,328.95 | ||||||||||
| Depreciation/Amortization | 44.43 | 61.21 | 59.59 | 72.08 | 95.72 | 116.09 | 125.30 | 130.80 | 135.40 | 136.87 | ||||||||||
| PBIT | 563.78 | 649.53 | 622.96 | 515.43 | 675.88 | 908.45 | 919.68 | 751.09 | 1,121.14 | 1,192.08 | ||||||||||
| Interest & Other Items | 4.89 | 1.36 | 0.41 | 1.16 | 11.91 | 8.27 | 10.20 | 5.84 | 7.21 | 10.77 | ||||||||||
| PBT | 558.89 | 648.17 | 622.55 | 514.27 | 663.97 | 900.18 | 909.48 | 745.25 | 1,113.93 | 1,181.31 | ||||||||||
| Taxes & Other Items | 143.28 | 141.34 | 153.91 | 127.30 | 196.27 | 246.31 | 196.80 | 157.27 | 297.76 | 306.31 | ||||||||||
| Net Income | 415.61 | 506.83 | 468.64 | 386.97 | 467.70 | 653.87 | 712.68 | 587.98 | 816.17 | 875.00 | ||||||||||
| EPS | 31.36 | 38.23 | 35.19 | 29.18 | 35.42 | 49.73 | 54.78 | 45.94 | 64.43 | 69.07 | ||||||||||
| DPS | 5.33 | 8.67 | 0.00 | 6.00 | 8.67 | 6.33 | 6.33 | 7.00 | 51.00 | 26.00 | ||||||||||
| Payout ratio | 0.17 | 0.23 | 0.00 | 0.21 | 0.24 | 0.13 | 0.12 | 0.15 | 0.79 | 0.38 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ajanta Pharma Ltd | 44.27 | 10.13 | 1.79% |
| Sun Pharmaceutical Industries Ltd | 45.12 | 6.44 | 0.75% |
| Cipla Ltd | 28.85 | 4.44 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.10 | 16.69 | 0.83% |
Price Comparison
Compare AJANTPHARM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Ajanta Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.5013% | Percentage of the fund’s portfolio invested in the stock 0.87% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 143/234 (-81) |
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1051% | Percentage of the fund’s portfolio invested in the stock 1.51% | Change in the portfolio weight of the stock over the last 3 months -0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/69 (0) |
Kotak Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8284% | Percentage of the fund’s portfolio invested in the stock 1.68% | Change in the portfolio weight of the stock over the last 3 months -0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/83 (+24) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Ajanta Pharma Ltd
Events
Dividend Trend
Dividend Yield
Current dividend yield is 1.79%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹17.88 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 6, 2024
Dividend/Share
₹28.00
Ex DateEx Date
Nov 6, 2024
Cash Dividend
Ex DateEx DateFeb 8, 2024
Dividend/Share
₹26.00
Ex DateEx Date
Feb 8, 2024
Cash Dividend
Ex DateEx DateAug 4, 2023
Dividend/Share
₹10.00
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateAug 4, 2023
Dividend/Share
₹15.00
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateNov 11, 2022
Dividend/Share
₹7.00
Ex DateEx Date
Nov 11, 2022
Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 2982.3, up 1.25% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 1.39% on the day, quoting at 23674.85. The Sensex is at 78171.81, up 1.32%. Ajanta Pharma Ltd has risen around 1.22% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has risen around 2.56% in last one month and is currently quoting at 21740.1, up 0.71% on the day. The volume in the stock stood at 25123 shares today, compared to the daily average of 1.02 lakh shares in last one month.The PE of the stock is 43.16 based on TTM earnings ending September 24.Powered by Capital Market - Live
Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2929.25, up 1.39% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.25% on the day, quoting at 23745.85. The Sensex is at 78340.19, up 1.29%. Ajanta Pharma Ltd has slipped around 6.72% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has slipped around 5.27% in last one month and is currently quoting at 21544.15, up 1.67% on the day. The volume in the stock stood at 16566 shares today, compared to the daily average of 1.04 lakh shares in last one month.The PE of the stock is 42.23 based on TTM earnings ending September 24.Powered by Capital Market - Live
Ajanta Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2767.25, down 2.49% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is down around 0.94% on the day, quoting at 23659.1. The Sensex is at 78018.99, down 0.83%.Ajanta Pharma Ltd has lost around 15.06% in last one month.Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has eased around 7.95% in last one month and is currently quoting at 22151.6, down 1.6% on the day. The volume in the stock stood at 39531 shares today, compared to the daily average of 1.11 lakh shares in last one month.The PE of the stock is 41.55 based on TTM earnings ending September 24.Powered by Capital Market - Live
Ajanta Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 3079.05, up 2.75% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.6% on the day, quoting at 24194.3. The Sensex is at 79405.35, down 0.67%. Ajanta Pharma Ltd has dropped around 5.36% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has dropped around 2.54% in last one month and is currently quoting at 22374.95, up 1.48% on the day. The volume in the stock stood at 92922 shares today, compared to the daily average of 1.46 lakh shares in last one month.The PE of the stock is 43.8 based on TTM earnings ending September 24.Powered by Capital Market - Live
Net profit of Ajanta Pharma rose 10.84% to Rs 216.48 crore in the quarter ended September 2024 as against Rs 195.30 crore during the previous quarter ended September 2023. Sales rose 15.38% to Rs 1186.64 crore in the quarter ended September 2024 as against Rs 1028.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1186.641028.44 15 OPM %26.2228.26 - PBDT324.63309.65 5 PBT290.24275.94 5 NP216.48195.30 11 Powered by Capital Market - Live
Ajanta Pharma has fixed 6th November 2024 as the record date for payment of 1st interim dividend.Powered by Capital Market - Live
Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 28 October 2024, has recommended a First Interim dividend of Rs.28 per share (i.e.1400%), subject to the approval of the shareholders.Powered by Capital Market - Live
Ajanta Pharma has fixed 06 November 2024 as record date for payment of interim dividend, if declared. Powered by Capital Market - Live
Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2974.35, down 0.1% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.31% on the day, quoting at 24547.8. The Sensex is at 80424.19, up 0.25%.Ajanta Pharma Ltd has eased around 7.72% in last one month.Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has eased around 1.88% in last one month and is currently quoting at 22828.2, down 0.33% on the day. The volume in the stock stood at 51692 shares today, compared to the daily average of 1.66 lakh shares in last one month.The PE of the stock is 44.75 based on TTM earnings ending June 24.Powered by Capital Market - Live
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.64%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.95% to 1.14%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 16.1%, vs industry avg of 15.27%